Your browser doesn't support javascript.
loading
A single-arm pilot of a web-based intervention to improve itch-related quality of life.
Heckman, C J; Riley, M; Niu, Z; Lu, S-E; Valdes-Rodriguez, R; Yosipovitch, G.
Afiliación
  • Heckman CJ; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Riley M; Metronic Inc., Denver, CO, USA.
  • Niu Z; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Lu SE; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Valdes-Rodriguez R; Department of Dermatology, University of Arkansas Medical Center, Little Rock, AR, USA.
  • Yosipovitch G; Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA.
J Eur Acad Dermatol Venereol ; 36(1): 108-112, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34549834
ABSTRACT

BACKGROUND:

Many patients with chronic itch and atopic dermatitis (AD) or psoriasis do not receive/use available medical and psychosocial treatments properly due to system, provider and/or patient factors.

OBJECTIVE:

An educational website (ITCH-RELIEF) to improve itch-related quality of life (QoL) for adults with AD or psoriasis and chronic itch was developed and assessed. ITCH RELIEF stands for Interactive Toolbox of Comprehensive Health Resources to Enhance Living with Itch - Educational Facilitation (for Adults).

METHODS:

Single-arm pre- and post-test design with 1-month follow-up (N = 137 at baseline).

RESULTS:

There was statistically and clinically significant improvement in the primary outcome of itch-related QoL impairment as assessed by the ItchyQoL from baseline [M = 78.9, 95% confidence interval (CI) = 75.9, 81.9] to follow up (M = 75.4, CI = 72.4, 78.5), P = 0.007, as well as statistically significant improvement in several itch-related secondary outcomes (all Ps < 0.05).

CONCLUSIONS:

This study demonstrated initial effectiveness of an online intervention to improve itch-related QoL among individuals with AD or psoriasis and chronic itch. Future studies should address limitations by randomizing more heterogeneous participants, utilizing a longer follow-up and assessing medication use.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Dermatitis Atópica / Intervención basada en la Internet Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Dermatitis Atópica / Intervención basada en la Internet Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos